About Abveris
Abveris is a Healthcare company based in Quincy (United States) founded in 2014 by Garren Hilow, and was acquired by Twist Bioscience in November 2021. Monoclonal antibodies are discovered rapidly using transgenic rodents. Abveris has raised $1 million across 1 funding round from investors including Twist Bioscience. Its chief executive, as recorded, is Garren Hilow. Its focus areas include Biopharma Outsourcing, CDMO, Biologics and Life Sciences. Its competitors include KBI Biopharma, GenScript and Aldevron; 2 of its 3 listed competitors have raised funding.
Company details
Abveris was founded in 2014 and is based in Quincy, United States, within the biotechnology sector. Transgenic rodents are utilized by the company to generate hybridomas that produce more immunogenic antibodies. Services encompass custom antibody production for therapeutic uses, monoclonal antibody manufacturing, and provision of antibodies as reagents for research applications. Operations focus on enhancing antibody immunogenicity through advanced hybridoma technology.
- Headquarters Quincy, United States
- Founders Garren Hilow
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website abveris.com
- Social LinkedIn X Facebook YouTube
- Acquired by Twist Bioscience (Nov 2021)
- Total Equity Funding$1M (USD)
in 1 rounds
- Latest Funding Round$1M (USD), Seed
Oct 2019
- Investors
- Acquired byTwist Bioscience
(Nov 2021)
Apps and channels of Abveris
its YouTube channel Lazada Indonesia has 13.5K subscribers and 30 videos.
Videos from Abveris
The most watched videos on Abveris's YouTube channel, Lazada Indonesia (13.5K subscribers). Click a video to play it here.
More on Lazada Indonesia.
Funding Insights of Abveris
Abveris has successfully raised a total of $1M through 1 strategic funding round. The most recent funding activity was a Seed round of $1 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1M
- Total Rounds 1
- Last Round Seed — $1M
- First Round $1M
(Oct 2019)
All 1 funding rounds of Abveris with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2019 | $1M | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Abveris
Abveris has secured backing from 1 investor. Prominent investors backing the company include Twist Bioscience.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Synthetic DNA is synthesized via a semiconductor-based platform. | 2013 | twistbioscience.com | San Francisco, United States |
Investor details for Abveris
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Abveris
24 people are tracked at Abveris (8 in leadership, 16 in team).
| Name | Role | Group |
|---|---|---|
Garren Hilow | Co-Founder & CEO | Leadership |
Tracey Mullen | CEO | Leadership |
Feng Gao | Director, Molecular Biology & Antibody Engineering | Leadership |
Vishal Kamat | Director, Antibody Characterization | Leadership |
Ryan Kelly | Head of Business Development in vivo AB Discovery Services | Leadership |
Yi-Pin Chang | Director of Protein Analytics | Leadership |
Chloe Emery | Director, Vivarium | Leadership |
Laurie Vallas | Director Business Operations | Leadership |
Roxann Guerrette | Alliance Manager | Team |
Braedon Williams | Research Associate | Team |
Brooke Mcisaac | Research Associate I | Team |
Alex Lopez | Vivarium Manager | Team |
Justin Stolte | Senior Research Associate | Team |
Melissa Caffrey | Research Associate | Team |
Jennifer Walker | GM, In Vivo Discovery Services | Team |
Shaun Josephs | Facilities Manager | Team |
Brianna KYC | Animal Care Technician II | Team |
Prasana Parasuraman | Project Manager | Team |
Mercedes Hurtado | Animal Research Technologist I | Team |
Christine Ngo | Research Associate I | Team |
4 more people are available in the full profile.
Complete people profiles for Abveris
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Abveris
3 dated milestones of Abveris across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Abveris is founded.
- Funding First funding round of $1.0M.
- Exit Acquired by Twist Bioscience.
Competitors of Abveris
Abveris has 3 listed competitors in our database, 2 of them funded. They include KBI Biopharma, GenScript and Aldevron.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kbibiopharma.com | 1996 | Durham, United States | $17M | 1,243 | Provider of protein formulation, process & cell line development, and cGMP services | |
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| aldevron.com | 1998 | Fargo, United States | 747 | Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications |
Detailed competitors of Abveris
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Abveris (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Abveris
Complete news archive for Abveris
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abveris
Abveris was founded in 2014 and raised its 1st funding round 5 years after it was founded.
Abveris is headquartered in Quincy, United States.
Garren Hilow is the CEO of Abveris, as recorded in our data. They have also founded this company.
Abveris is a funded company, having raised a total of $1M across 1 funding round to date. The company's 1st funding round was a Seed of $1M, raised on Oct 2019.
Abveris was founded in 2014 and is based in Quincy, United States, within the biotechnology sector. Transgenic rodents are utilized by the company to generate hybridomas that produce more immunogenic antibodies. Services encompass custom antibody production for therapeutic uses, monoclonal antibody manufacturing, and provision of antibodies as reagents for research applications. Operations focus on enhancing antibody immunogenicity through advanced hybridoma technology.
Abveris's top competitors include KBI Biopharma, GenScript and Aldevron.
Abveris has 1 investor. Key investors include Twist Bioscience.
Yes. Abveris was acquired by Twist Bioscience in November 2021.